| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6113600 | Critical Reviews in Oncology/Hematology | 2016 | 49 Pages |
Abstract
Proper patient selection, development of predictive biomarkers and randomized controlled studies are required to develop evidence-based concepts for recurrent glioblastoma.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Katharina Seystahl, Wolfgang Wick, Michael Weller,